|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
-1.96% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | 1.97x | 20.32x | 43.14x | 62.49M | |
| -.--% | -.--% | 18.08x | 1.58x | 0.76x | 11.93x | 12.81x | 15.56B | |
| -.--% | 0.96% | 21.53x | 2.62x | 1.07x | 16.55x | 16.92x | 7.18B | |
| 2.03% | 2.38% | 16.76x | 1.75x | 0.73x | 7.61x | 9.57x | 5.85B | |
| 3.22% | 3.56% | 13.33x | 2.01x | 0.85x | 6.14x | 8.04x | 3.78B | |
| 3.99% | 4.39% | 16.19x | 7.33x | 0.99x | 7.36x | 10.23x | 3.33B | |
| 5.6% | 6.22% | 14.77x | 4.43x | 1.25x | 7.59x | 14.72x | 3.3B | |
| 5.36% | 5.68% | 12.62x | 2.36x | 0.51x | 4.05x | 6.68x | 2.77B | |
| 1.75% | 2.2% | 23.41x | 3.96x | 0.67x | 8.62x | 14.08x | 1.7B | |
| 0.08% | -.--% | -48.62x | 2.14x | 0.36x | 14.37x | 203.82x | 1.12B | |
| 5.64% | 6.34% | 11.75x | 2.36x | 0.86x | 7.05x | 13.3x | 980M | |
| 4.3% | 4.84% | 11.81x | 0.84x | 0.28x | 2.7x | 5.56x | 935M | |
| 1.33% | 1.93% | 27.08x | 7.31x | 0.98x | 13.36x | 21.13x | 823M | |
| 0.39% | 0.41% | 13.18x | 1.84x | 0.64x | 7.9x | 12.81x | 653M | |
| Average | 2.59% | 2.99% | 11.68x | 3.12x | 0.85x | 9.68x | 28.06x | 3.43B | |
| Weighted average by Cap. | 1.76% | 2.11% | 15.85x | 2.63x | 0.83x | 10.21x | 16.81x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
